Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

Inclusion Criteria: * Subject must have been 18-65 years of age, of either sex and any race. * Subject must have had symptomatic allergic rhinitis with a total nasal symptom (congestion, rhinorrhea, sneezing, itching) severity score of \<6 but \>2; congestion must have been \<2. * Subject must have been free of any clinically significant disease (other than allergic rhinitis) that would interfere with study evaluations. * Subject must have understood and been able to adhere to the dosing and visit schedule. Exclusion Criteria: * Subject had used any investigational product within 30 days prior to enrollment. * Subject was in a situation or condition that, in the opinion of the investigator, may have interfered with optimal participation in the study. * Subject was participating in any other clinical study(ies). * Subject was using any nasal lavage fluid or spray. * Subject was using any perfume during the study day. * Subject was using any oral rinse during the study day. * Subject had used topical or oral nasal decongestants in the past 1 week. * Subject had used a nasal corticosteroid in the previous 2 weeks. * Subject had anosmia or ageusia (absence of the sense of smell or taste). * Subject had been using medications which are associated with anosmia or ageusia in the 2 weeks prior to testing. * Subject had a respiratory infection in the 2 weeks prior to testing.